Natixis

SEC CIK: 0001274981
Latest filing: Aug 13, 2026

SEC filings (opens in a new tab)

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by Natixis, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overview All 13F holders of VRTX Full Q2 2026 holdings

Shares (Q2 2026): 59,095
Value: $29.4M
% of portfolio: 0.1%
Quarters held: 21; Since Q1 2021

Holdings of VRTX by Natixis, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	59,095	$29.4M	0.1%	+10,903+22.6%	Added	Holders
Q1 2026	48,192	$21.5M	0.1%	−12,026−20.0%	Reduced	Holders
Q4 2025	60,218	$27.3M	0.1%	+30,412+102.0%	Added	Holders
Q3 2025	29,806	$11.7M	0.1%	−1,155−3.7%	Reduced	Holders
Q2 2025	30,961	$13.8M	0.1%	−24,473−44.1%	Reduced	Holders
Q1 2025	55,434	$26.8M	0.2%	+32,572+142.5%	Added	Holders
Q4 2024	22,862	$9.21M	0.1%	−13,865−37.8%	Reduced	Holders
Q3 2024	36,727	$17.1M	0.1%	−7,605−17.2%	Reduced	Holders
Q2 2024	44,332	$20.8M	0.1%	−306−0.7%	Reduced	Holders
Q1 2024	44,638	$18.7M	0.1%	−7,268−14.0%	Reduced	Holders
Q4 2023	51,906	$21.1M	0.2%	−129,266−71.3%	Reduced	Holders
Q3 2023	181,172	$63.0M	0.5%	+89,685+98.0%	Added	Holders
Q2 2023	91,487	$32.2M	0.3%	+73,987+422.8%	Added	Holders
Q1 2023	17,500	$5.51M	0.1%	−60,978−77.7%	Reduced	Holders
Q4 2022	78,478	$22.7M	0.1%	+55,193+237.0%	Added	Holders
Q3 2022	23,285	$6.74M	<0.1%	−9,232−28.4%	Reduced	Holders
Q2 2022	32,517	$9.16M	<0.1%	+27,221+514.0%	Added	Holders
Q1 2022	5,296	$1.38M	<0.1%	−15,127−74.1%	Reduced	Holders
Q4 2021	20,423	$4.49M	<0.1%	−166,652−89.1%	Reduced	Holders
Q3 2021	187,075	$33.9M	0.1%	+187,075	New	Holders
Q2 2021	0	$0	0.0%	−60,011−100.0%	Sold out	Holders
Q1 2021	60,011	$12.9M	<0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.